Mark Strobeck - 01 Oct 2026 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Reporting relationship: President and CEO, Director
Issuer ticker: RMTI
Reported as of: 01 Oct 2026
Net transaction value: -$8,420
SEC form: 4
Accepted by SEC: 05 Oct 2026, 16:03:44 UTC
Prior SEC filing: 06 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Megan Timmins, Attorney-in-fact for Mark Strobeck

Key filing fact

Mark Strobeck filed Form 4 for ROCKWELL MEDICAL, INC. (RMTI) on 05 Oct 2026.

Key facts

This page summarizes Mark Strobeck's Form 4 filing for ROCKWELL MEDICAL, INC. (RMTI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Oct 2026, 16:03.

Change

Previous filing in this sequence was filed on 06 Jul 2026.
Current net transaction value: -$8,420.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001599219 Primary reporting owner

Strobeck Mark

Relationship: President and CEO, Director
Address: 30142 WIXOM ROAD, WIXOM
Signature: /s/ Megan Timmins, Attorney-in-fact for Mark Strobeck
Signature date: 05 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMTI transaction

Common Stock

Sale

Transaction value: $8,420
Shares: -1,000
Change %: -1.6%
Price: $8.42
Shares after: 61,349
Date: 01 Oct 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2026.